企業プロフィール
Marinus 株価・ニュース・カタリスト
- ティッカー:
- MRNS
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for MRNS.
企業概要
事業概要
Marinus is a neuroscience company focused on seizure and neuropsychiatric disorders with a commercial and development mix. Its story has been shaped by efforts to turn CNS programs into durable value.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Marinus sits in specialty neuroscience biopharma.
ビジネスモデルの特徴
The business depends on product adoption, pipeline progress, and the ability to stabilize a concentrated CNS story.
バイオ業界での位置付け
Marinus is a catalyst-sensitive CNS name whose stock reacts to both commercial and clinical updates.
今後のカタリスト
- Marinus’s catalyst set is centered on ZTALMY and any strategic update that clarifies the company’s remaining value after the epilepsy program. The story is now more about what the company becomes next than about a broad pipeline.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。